View Document Preview and Link Document Date: 2011-10-03 04:02:16 Open Document File Size: 179,41 KB Share Result on Facebook
City Tokyo / Geneva / Memphis / Atlanta / Melbourne / London / / Company WHO Global / Essential Regulatory Laboratories / WHO H5 Reference Laboratory / WHO H5 Reference Laboratories / GAP / PP3 / / Event Product Recall / Product Issues / / Facility Originating laboratory / / IndustryTerm biological products / health-care products / expression products / diagnostic and pharmaceutical manufacturers / pharmaceuticals / pharmaceutical products / vaccine manufacturing capacity / / MedicalCondition H5 virus infection / High-growth reassortant influenza viruses / seasonal influenza / pandemic influenza preparedness vaccine virus / wild-type influenza viruses / influenza reference virus / INTERGOVERNMENTAL MEETING ON PANDEMIC INFLUENZA PREPAREDNESS / influenza reference viruses / pandemic influenza preparedness vaccine viruses / influenza viruses / Pandemic influenza / influenza virus / seasonal influenza viruses / influenza / human influenza / / Organization States / Recall World Health Assembly / World Health Organization / World Health Organization Secretariat / WHO PIP / WHO Collaborating Centre on Influenza / WHO Collaborating Centre for the Surveillance / Epidemiology and Control of Influenza / UN Committee for Development Policy / WHO Collaborating Centre for Studies / National Influenza Centre / / Position draft chair / Chair / representative / General / Director-General / / Product Doha Declaration / / ProvinceOrState World Health Organization Secretariat / / Technology 16 6.11 Technology / diagnostic tests / antibodies / / URL http / SocialTag 
Microsoft Word - PIP_IGM_WG6-en.doc